BIM
AZN icon

BlackRock Investment Management’s AstraZeneca AZN Stock Holding History

BlackRock Investment Management’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$164M Sell
3,001,274
-1,038,282
-26% -$59M 0.19% 106
2016
Q3 		$265M Buy
4,039,556
+436,038
+12% +$28.5M 0.33% 57
2016
Q2 		$218M Buy
3,603,518
+1,523,134
+73% +$88.5M 0.28% 77
2016
Q1 		$117M Buy
2,080,384
+219,022
+12% +$13.2M 0.15% 137
2015
Q4 		$126M Sell
1,861,362
-404,044
-18% -$26.5M 0.16% 126
2015
Q3 		$144M Buy
2,265,406
+95,148
+4% +$6.26M 0.19% 108
2015
Q2 		$138M Buy
2,170,258
+476,823
+28% +$32.6M 0.17% 122
2015
Q1 		$116M Buy
1,693,435
+38,280
+2% +$2.66M 0.15% 144
2014
Q4 		$116M Buy
1,655,155
+685,058
+71% +$49.1M 0.15% 145
2014
Q3 		$69.3M Buy
970,097
+445,770
+85% +$32.6M 0.1% 203
2014
Q2 		$39M Sell
524,327
-938,248
-64% -$67.8M 0.05% 333
2014
Q1 		$94.9M Buy
1,462,575
+101,367
+7% +$6.55M 0.14% 157
2013
Q4 		$80.8M Buy
1,361,208
+570,556
+72% +$31M 0.12% 180
2013
Q3 		$41.1M Buy
790,652
+143,790
+22% +$7.22M 0.07% 266
2013
Q2 		$30.6M Buy
+646,862
New +$32.9M 0.05% 319

Other funds holding AZN

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
EIP
Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
SCCM
Schafer Cullen Capital Management New York $491M AUM 41.48% 1-Year Est. Return

BlackRock Investment Management's AZN Position: Q4 2016 in Review

BlackRock Investment Management reduced its AstraZeneca (AZN) stake by 26% in Q4 2016, selling an estimated $59M and leaving 3,001,274 shares worth $164M. The position accounts for 0.19% of the portfolio, ranked #106.

BlackRock Investment Management first reported a position in AZN in Q2 2013 and has held it in 15 quarters since. The position peaked at $265M in Q3 2016. 450 funds tracked by Wall St. Rank hold AZN as of Q4 2016.

  • BlackRock Investment Management held 3,001,274 shares of AstraZeneca worth $164M as of Q4 2016.
  • BlackRock Investment Management sold 1,038,282 AstraZeneca shares in Q4 2016, an estimated $59M.
  • AstraZeneca made up 0.19% of BlackRock Investment Management's portfolio in Q4 2016, its #106 holding.
  • BlackRock Investment Management first reported a position in AstraZeneca in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Investment Management's AstraZeneca position peaked at $265M in Q3 2016.
  • 450 funds tracked by Wall St. Rank held AstraZeneca as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.